A detailed history of Regal Investment Advisors LLC transactions in Uni Qure N.V. stock. As of the latest transaction made, Regal Investment Advisors LLC holds 15,944 shares of QURE stock, worth $92,156. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,944
Previous 15,995 0.32%
Holding current value
$92,156
Previous $71,000 9.86%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$3.78 - $10.12 $192 - $516
-51 Reduced 0.32%
15,944 $78,000
Q2 2024

Aug 14, 2024

SELL
$4.39 - $5.43 $1,597 - $1,976
-364 Reduced 2.23%
15,995 $71,000
Q1 2024

May 15, 2024

BUY
$4.82 - $6.93 $1,282 - $1,843
266 Added 1.65%
16,359 $85,000
Q4 2023

Feb 14, 2024

BUY
$5.63 - $8.27 $11,969 - $17,582
2,126 Added 15.22%
16,093 $108,000
Q3 2023

Nov 13, 2023

BUY
$6.71 - $11.83 $93,718 - $165,229
13,967 New
13,967 $93,000

Others Institutions Holding QURE

About uniQure N.V.


  • Ticker QURE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,729,100
  • Market Cap $270M
  • Description
  • uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...
More about QURE
Track This Portfolio

Track Regal Investment Advisors LLC Portfolio

Follow Regal Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.